0
X-rays and artificial intelligence offer a potential diagnostic tool for COVID-19
Researchers from the Universidade Federal do Ceará, Instituto Federal do Ceará and Universidade de Fortaleza (all Fortaleza, Brazil) report on…
Browsing: Clinical > Diagnosis
0
COVID-19 biomarkers identified that could diagnose and predict outcomes
Three blood metabolites have been identified by Canadian researchers that appear to be affected by COVID-19, which could be measured in…
0
What are the long-term effects of COVID-19 infection?
A recently published review, ‘Living with COVID’, details the most up-to-date information surrounding ongoing COVID-19 symptoms – often termed long…
0
Coronavirus research tools: Cayman Chemical
Identifying drugs and developing rapid and accurate diagnostic tests for SARS-CoV-2 are currently at the forefront of the infectious disease…
0
A COVID-19 machine learning model based on standard laboratory tests – an interview with Steven Phelps and Vafa Bayat of Bitscopic
In an interview with leaders from Bitscopic, we learn about the predictive model, with a machine learning algorithm that they use to predict the diagnostic fingerprint of COVID-19, using standard laboratory tests.
0
COVID-19 antibody assay can analyze up to 40,000 samples daily
LGC (Cambridge, UK) has developed a COVID-19 antibody assay that can analyze up to 40,000 samples daily and is suitable for…
0
New antibody test for SARS-CoV-2
A new SARS-CoV-2 antibody test has been developed with improved accuracy and higher sample throughput at a lower cost in…
0
In Focus: studying the COVID-19 pandemic – a Special Focus Issue
Infectious Diseases Hub has partnered with Future Virology to bring you exclusive access to articles and features in the recent Special Focus Issue.
0
Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection
In this Special Report from the ‘COVID-19: studying the global pandemic’ Special Focus Issue authors theorize about the identification of asymptomatic patients and the impact this has on the spread of COVID-19.
0
Confronting COVID-19 head on at the Wyss Institute
Harvard’s Wyss Institute is leveraging its unique technology innovation capabilities to develop diagnostic, therapeutic, and vaccine interventions for COVID-19 at lightning speed.